Advertisement
Advertisement
U.S. markets open in 5 hours 4 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Coherus BioSciences, Inc. (CHRS)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
Visitors trend2W10W9M
12.97+1.91 (+17.27%)
At close: 04:00PM EDT
12.58 -0.39 (-3.01%)
Pre-Market: 04:04AM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Relative Strength Index (RSI)

Relative Strength Index (RSI)

Performance Outlook
Previous Close11.06
Open11.39
Bid0.00 x 3200
Ask0.00 x 1100
Day's Range11.39 - 12.98
52 Week Range5.60 - 19.32
Volume1,950,572
Avg. Volume1,121,501
Market Cap1.008B
Beta (5Y Monthly)1.18
PE Ratio (TTM)N/A
EPS (TTM)-2.75
Earnings DateNov 07, 2022 - Nov 11, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est19.57
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for CHRS

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Coherus BioSciences, Inc.
    CHRS: Raising target price to $8.00COHERUS BIOSCIENCES INC has an Investment Rating of HOLD; a target price of $8.000000; an Industry Subrating of High; a Management Subrating of Low; a Safety Subrating of Medium; a Financial Strength Subrating of Low; a Growth Subrating of Low; and a Value Subrating of High.
    Rating
    Fair Value
    Economic Moat
    last monthArgus Research
View more
Advertisement
Advertisement